We’re happy to connect.
If you have interest in learning more about a subscription to All Things Biosimilar, would like engage Bourgoin Insights Group on a project, or have general questions, then let us know! The form on the right is the best way to connect with us on the above topics, or others. We look forward to hearing from you. Thanks!
Meet the Founder
Andrew Bourgoin
PRINCIPAL, Bourgoin Insights Group, LLC
Andrew Bourgoin is a dynamic and accomplished leader with over 15 years of experience in the U.S. pharmaceutical market, including executive roles across multiple industry-leading companies. Driven by a deep commitment to improving patient access to affordable medicines, Andrew has built a distinguished career in the U.S. biosimilars sector. His tenure includes impactful roles at top organizations such as Boehringer Ingelheim, Alvotech, Biogen, Celltrion, and Adello. Andrew began his professional journey as an analyst at Thomson Reuters, where he managed industry-leading biosimilar datasets and established himself as an expert in the field. Recognized for his exceptional performance and influential leadership, Andrew’s commitment to advancing the U.S. biosimilars market is unlike most.
The founding of Bourgoin Insights Group, LLC reflects Andrew’s entrepreneurial vision and unwavering dedication to delivering exceptional value to clients. Through initiatives like All Things Biosimilar, Andrew continues to champion his passion for the U.S. biosimilars market and its critical stakeholders.
Based in his home state of Maine, Andrew aims to grow Bourgoin Insights Group beyond its current focus on biosimilars, extending its expertise to offer innovative business solutions to organizations within the local community.